Skip to main content

Table 4 Pain intensity assessment and opioid dosage requirements of the 87 patients

From: A systematic review of the risk factors for clinical response to opioids for all-age patients with cancer-related pain and presentation of the paediatric STOP pain study

 

mean ± SD

PIt0 (Pain Intensity at t0)

4.34 ± 2.17

PI24h (Pain intensity at t24h)

2.04 ± 2.56

PIend (Pain intensity at tend)

1.07 ± 2.19

Timetot (time to the minor PI)

140.43 ± 63.89

 

N

%

PIt0 (grouped)

 ≤4

47

54.02

 > 4

40

45.98

ΔVAS (PIt0 - PIt24h; grouped)

  ≤ 2

46

52.87

  > 2

39

44.83

Responders (PIend equal to 0)

 No

23

26.44

 Yes

64

73.56

Pain location

 Abdominal

12

13.79

 Oral cavity

43

49.43

 Skeletal - Muscle

14

16.09

 Other

18

20.69

Drug

 morphine

60

68.97

 tramadol

19

21.84

 oxycodone

2

2.30

 codeine

2

2.30

 more than one

4

4.60

Dose24h (mg/kg)

  ≤ 0.2

24

27.59

 0.2- ≤ 0.42

20

22.99

 0.42- ≤ 0.50

22

25.29

  > 0.50

19

21.84

 Missing

2

2.30

Dosetot (mg/kg)

  ≤ 1.2

21

24.14

 1.2- ≤ 2.16

20

22.99

 2.16- ≤ 3.42

24

27.59

  > 3.42

22

25.29

  1. PI Pain Intensity
Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us